Narval CC Mandibular Repositioning Device in the Second-line Treatment of Severe Obstructive Sleep Apnea Hypopnea (OSAH)

CompletedOBSERVATIONAL
Enrollment

360

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

February 28, 2019

Study Completion Date

February 27, 2019

Conditions
Obstructive Sleep Apnea Syndrome
Interventions
DEVICE

ORM Narval MRD

Trial Locations (26)

Unknown

Fondation Bon Sauveur / cabinet médical / cabinet dentaire, Albi

CH Antibes / cabinet dentaire, Antibes

CH Béziers, Béziers

CHU Avicennes, Bobigny

Polyclinique du Tondu / cabinet dentaire, Bordeaux

CHG Chalon en Champagne, Châlons-en-Champagne

CH Compiègne Senlis / cabinets dentaires, Compiègne

CHU Grenoble, Grenoble

Cabinet médical / cabinet dentaire, Lagny

CHRU Lille, Lille

Cabinet médical Lyon, Lyon

CHU La Timone / cabinet médical, Marseille

CHRU Montpellier / Clinique Beau Soleil / Faculté d'Odontologie / cabinet dentaire, Montpellier

CH Montreuil, Montreuil

Centre Médical Plateau de Haye / cabinet médical / cabinet dentaire, Nancy

Maison de la Mutualité / polyclinique de l'Atlantique, Nantes

Cabinet médical / cabinet dentaire, Nice

Hôpital Bichat Claude Bernard, Paris

Hôpital Pitié Salpetriere, Paris

Hôtel Dieu, Paris

CHU Poitiers, Poitiers

CHRU Rennes / polyclinique St Laurent / cabinet dentaire, Rennes

CHRU Rouen, Rouen

CHU Toulouse, Toulouse

Clinique de l'Union, Toulouse

CH Valence, Valence

Sponsors

Lead Sponsor

All Listed Sponsors
lead

ResMed

INDUSTRY

NCT01326143 - Narval CC Mandibular Repositioning Device in the Second-line Treatment of Severe Obstructive Sleep Apnea Hypopnea (OSAH) | Biotech Hunter | Biotech Hunter